Cancer Family
Malignant Genitourinary System Neoplasm
CI-CAN-00000233Explore in graph →
3,555 active trials61 approved drugs296 evidence items
- NCIt
- C156484
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000233Explore in graph →
Clinical trials
15,552 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,964)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03676946 | A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Locally Advanced and Metastatic Urothelial Carcinoma | unknown | Phase 1 / Phase 2 | 15 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | Sep 26, 2018 | clinicaltrials |
| NCT02005965 | Low Rectal Cancer Study (MERCURY II)(MERCURY II) | unknown | — | 542 | Royal Marsden NHS Foundation TrustOTHER | 3 | Sep 18, 2018 |
| clinicaltrials |
| NCT01037049 | Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks | unknown | Phase 2 | 237 | Royal Marsden NHS Foundation TrustOTHER | 4 | Sep 17, 2018 | clinicaltrials |
| NCT01995942 | Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial(MARVEL) | unknown | — | 246 | Royal Marsden NHS Foundation TrustOTHER | 1 | Sep 14, 2018 | clinicaltrials |
| NCT02058680 | Phase 1A/1B Study of PSA/IL-2/GM-CSF Vaccine for Recurrent Prostate Cancer in Hormone Naive and Hormone Independent Patients(PSA) | unknown | Phase 1 | 48 | OncBioMune PharmaceuticalsOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT03170570 | the Re-irradiation of Recurrent Cervical Cancer by IMRT | unknown | N/A | 108 | Sun Yat-sen UniversityOTHER | 1 | Sep 10, 2018 | clinicaltrials |
| NCT03662958 | Comparison of a Novel Leuprolide With Market Leuprolide | unknown | N/A | 48 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | Sep 10, 2018 | clinicaltrials |
| NCT03658525 | Prostate Radiotherapy Integrated With Simultaneous MRI (The PRISM Study)(PRISM) | unknown | N/A | 30 | Royal Marsden NHS Foundation TrustOTHER | 1 | Sep 7, 2018 | clinicaltrials |
| NCT03586947 | Association Between Vitamin D and the Risk of Uterine Fibroids(ABVDATROUF) | unknown | N/A | 1,160 | Second Affiliated Hospital of Wenzhou Medical UniversityOTHER | 1 | Sep 5, 2018 | clinicaltrials |
| NCT03655977 | Radiation Therapy Planning by Multi-parametric PET/MRI Imaging in Patients With Cervical Cancer(RaPiCCa) | unknown | N/A | 25 | Rigshospitalet, DenmarkOTHER | 1 | Sep 4, 2018 | clinicaltrials |
| NCT02295449 | Quantitative Prostate Cancer Contrast-enhanced Ultrasound(SONOCAP) | unknown | N/A | 130 | Hospices Civils de LyonOTHER | 1 | Aug 31, 2018 | clinicaltrials |
| NCT03050047 | A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 15 | BiocadINDUSTRY | 1 | Aug 31, 2018 | clinicaltrials |
| NCT03650946 | Clinical Application of 68Ga-PSMA PET in Prostate Cancer | unknown | — | 150 | National Taiwan University HospitalOTHER | 1 | Aug 29, 2018 | clinicaltrials |
| NCT02981901 | Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France(Ovaire01) | unknown | — | 376 | Centre Leon BerardOTHER | 1 | Aug 23, 2018 | clinicaltrials |
| NCT03640299 | The Safety and Efficacy of Enhanced Recovery After Surgery on Clinical and Immune Outcomes for Gynecological Oncology | unknown | N/A | 80 | Shanghai First Maternity and Infant HospitalOTHER | 1 | Aug 23, 2018 | clinicaltrials |
| NCT02681432 | Hyperthermic Intraperitoneal Chemotherapy With Paclitaxel in Advanced Ovarian Cancer(hipecova) | unknown | Phase 3 | 60 | PEDRO VILLAREJO CAMPOSOTHER | 1 | Aug 21, 2018 | clinicaltrials |
| NCT00753610 | Endothelial Progenitor Cells in Cervical Cancer Patients Receiving Chemoradiation(EPC) | unknown | — | 30 | Mackay Memorial HospitalOTHER | 1 | Aug 17, 2018 | clinicaltrials |
| NCT03082274 | Prospective Validation of Prostate Biomarkers for Repeat Biopsy(PRIORITY) | unknown | — | 1,000 | MDx HealthINDUSTRY | 1 | Aug 17, 2018 | clinicaltrials |
| NCT03632980 | Dynamic Focusing Evaluation for Prostate Cancer Treatment(FOC/DYN) | unknown | N/A | 180 | EDAP TMS S.A.INDUSTRY | 1 | Aug 16, 2018 | clinicaltrials |
| NCT03469531 | Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer | unknown | Phase 2 | 100 | Zhujiang HospitalOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT02919371 | Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA) | unknown | Phase 1 / Phase 2 | 77 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT03623425 | Comparison of PET With 68GA-PSMA-11 and 18F-Fluorocholine for Recurrence in Men With Prostate Cancer(TEPGALCHOL) | unknown | Phase 3 | 46 | Central Hospital, Nancy, FranceOTHER | 1 | Aug 9, 2018 | clinicaltrials |
| NCT02525068 | A Study of Enzalutamide in Combination With AZD5363 in Patients With mCRPC(RE-AKT) | unknown | Phase 2 | 136 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 8, 2018 | clinicaltrials |
| NCT03618706 | Standard of Care Therapy With Involved Field Radiation Therapy for Selective Recurrent Ovarian Cancer | unknown | Phase 2 | 107 | Yonsei UniversityOTHER | 1 | Aug 7, 2018 | clinicaltrials |
| NCT02783235 | Cervical Cancer Screening : Video Based Tutorials for ANMs/ASHAs/PHWs | unknown | N/A | 50 | Tata Memorial HospitalOTHER_GOV | 1 | Aug 6, 2018 | clinicaltrials |
| NCT03386695 | Acceptability and Validity of Self Sampling for High Risk HPV Detection Among Women in Maharashtra(HPV) | unknown | N/A | 1,600 | Tata Memorial HospitalOTHER_GOV | 1 | Aug 6, 2018 | clinicaltrials |
| NCT00916708 | Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients(TOTEM) | unknown | N/A | 1,884 | Azienda Ospedaliera San Giovanni BattistaOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03611179 | Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer | unknown | Phase 2 | 40 | Nada Hassan SalahOTHER | 0 | Aug 2, 2018 | clinicaltrials |
| NCT03577132 | The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer | unknown | N/A | 20 | Seoul National University HospitalOTHER | 0 | Jul 31, 2018 | clinicaltrials |
| NCT03597087 | The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study | unknown | N/A | 289 | Seoul National University HospitalOTHER | 1 | Jul 24, 2018 | clinicaltrials |
| NCT03413007 | Correlation Between iXip and Final Pathology Specimen From Radical Prostatectomy: a Multicenter Prospective Trial | unknown | — | 300 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Jul 19, 2018 | clinicaltrials |
| NCT03183700 | Self Collected Sampling in Non-attendees Cervical Cancer Screening: DNA Test and Molecular Triage for HPV Positive Women | unknown | N/A | 8,000 | Cancer Prevention and Research Institute, ItalyOTHER | 1 | Jul 17, 2018 | clinicaltrials |
| NCT00407875 | Intensity Modulated Versus Interstitial - Radiation Therapy | unknown | N/A | 50 | British Columbia Cancer AgencyOTHER | 1 | Jul 13, 2018 | clinicaltrials |
| NCT03283943 | PDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers. | unknown | Phase 1 | 22 | British Columbia Cancer AgencyOTHER | 1 | Jul 11, 2018 | clinicaltrials |
| NCT03580239 | Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency | unknown | Phase 3 | 120 | Tianjin Medical University Second HospitalOTHER | 1 | Jul 9, 2018 | clinicaltrials |
| NCT03550703 | Open Label Immunotherapy of Myoma(V3-myoma) | unknown | Phase 2 | 30 | Immunitor LLCINDUSTRY | 1 | Jul 6, 2018 | clinicaltrials |
| NCT03567655 | Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer | unknown | Phase 2 | 41 | Asan Medical CenterOTHER | 1 | Jun 26, 2018 | clinicaltrials |
| NCT03570242 | WB-EMS and Individualized Nutritional Support in Gynecological Cancer Patients | unknown | N/A | 150 | University of Erlangen-Nürnberg Medical SchoolOTHER | 1 | Jun 26, 2018 | clinicaltrials |
| NCT03563443 | Genomic Imprinting Testing for Diagnosis of Bladder Cancer | unknown | — | 300 | Changhai HospitalOTHER | 1 | Jun 20, 2018 | clinicaltrials |
| NCT03238066 | Salvage Brachytherapy and Interstitial Hyperthermia for Locally Recurrent Prostate Carcinoma Following Radiation Therapy(Prostata-BT-HT) | unknown | N/A | 77 | University of Erlangen-Nürnberg Medical SchoolOTHER | 2 | Jun 7, 2018 | clinicaltrials |
| NCT03549195 | TMTP1 Targeting Micro-metastasis LN in Laparoscopic SLN Detection in Cervical Cancer | unknown | N/A | 120 | Huazhong University of Science and TechnologyOTHER | 1 | Jun 7, 2018 | clinicaltrials |
| NCT03546855 | Apatinib Treating Patients With Advanced Cervical Cancer After Radiotherapy and First-line Chemotherapy. | unknown | Phase 2 | 69 | Anhui Provincial HospitalOTHER_GOV | 0 | Jun 6, 2018 | clinicaltrials |
| NCT03547375 | Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy | unknown | Phase 2 | 69 | Anhui Provincial HospitalOTHER_GOV | 0 | Jun 6, 2018 | clinicaltrials |
| NCT03538704 | Effect of Fertility-sparing Therapy of Early Endometrial Cancer(ECFerSp) | unknown | N/A | 80 | Peking University People's HospitalOTHER | 1 | May 29, 2018 | clinicaltrials |
| NCT03539328 | Study on MK-3475 Plus Chemotherapy Versus Chemotherapy Alone in Recurrent, Platinum-resistant Ovarian Cancer(MITO27) | unknown | Phase 2 | 138 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | May 29, 2018 | clinicaltrials |
| NCT03399344 | Clinical Impact of Dedicated MR Staging of Ovarian Cancer(MRStagingOC) | unknown | N/A | 270 | The Netherlands Cancer InstituteOTHER | 1 | May 22, 2018 | clinicaltrials |
| NCT03341845 | Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC | unknown | Phase 2 | 40 | The Netherlands Cancer InstituteOTHER | 1 | May 21, 2018 | clinicaltrials |
| NCT03516045 | A Study of 18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate Cancer | unknown | Phase 1 / Phase 2 | 65 | Xiangya Hospital of Central South UniversityOTHER | 1 | May 17, 2018 | clinicaltrials |
| NCT03525652 | Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment | unknown | Phase 1 / Phase 2 | 30 | The First Affiliated Hospital of Guangdong Pharmaceutical UniversityOTHER | 1 | May 16, 2018 | clinicaltrials |
| NCT03526809 | Molecular Imaging and Spectroscopy With Stable Isotopes in Oncology and Neurology(MISSION-ovary) | unknown | — | 40 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | May 16, 2018 | clinicaltrials |
Data updated 24 days agoSource updated Sep 26, 2018source: clinicaltrials